Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] Professors Erika Lietzan and Kristina Acri Argue That Current Data Do Not Support Evergreening Allegations

Posted on: May 2, 2023May 13, 2026Biotech , Healthcare , Patents , Pharma

By Jack Ring In their forthcoming paper, Solutions Still Searching for a Problem: A Call for Relevant Data to Support “Evergreening” Allegations,[1] C-IP2 Senior Scholars Erika Lietzan of Mizzou Law […]

[Archived Post] Philips and Thales’ Standard Essential Patent Fight at the Federal Circuit, District Court, and ITC

Posted on: August 18, 2022May 13, 2026FTC , ITC , Patents

The following post comes from Jack Ring, a rising 2L at Scalia Law and a Research Assistant at C-IP2. Click here for a related post. I. INTRODUCTION On July 13, […]

[Archived Post] Professor Tabrez Ebrahim on Clean and Sustainable Technological Innovation

Posted on: March 25, 2021May 13, 2026Innovation , Patents

The following post comes from Associate Professor of Law Tabrez Ebrahim of California Western School of Law in San Diego, California. By Tabrez Ebrahim What role should patent law have […]

[Archived Post] Accenture Report Outlines How 5G Technology Accelerates Economic Growth

Posted on: March 8, 2021May 13, 2026High Tech Industry , Patents

The following post comes from Wade Cribbs, a 2L at Scalia Law and a Research Assistant at CPIP. By Wade Cribbs Everyone in the technology industry knows that 5G is […]

[Archived Post] UC Hastings’ Evergreen Drug Patent Search Database: A Look Behind the Statistics Reveals Problems with this Approach to Identifying and Quantifying So-Called “Evergreening”

Posted on: March 4, 2021May 13, 2026Patents , Pharma

Professor Robin Feldman’s reply to this post, and our response, can be read read here. The Center for Innovation, housed at the University of California Hastings College of the Law, has […]

[Archived Post] Professors Erika Lietzan and Kristina Acri on “Distorted Drug Patents”

Posted on: February 12, 2021May 13, 2026Patent Law , Patents , Pharma

The following post comes from Austin Shaffer, a 2L at Scalia Law and a Research Assistant at CPIP. By Austin Shaffer In their new paper, Distorted Drug Patents, CPIP Senior […]

[Archived Post] Professor David Taylor on Patent Eligibility and Investment

Posted on: February 4, 2021May 13, 2026Patentability Requirements , Patents , Supreme Court

The following post comes from Terence Yen, a 4E at Scalia Law and a Research Assistant at CPIP. By Terence Yen In his new paper, Patent Eligibility and Investment, Professor […]

[Archived Post] USPTO-DOJ Workshop on Promoting Innovation in the Life Science Sector: Day Two Recap

Posted on: January 13, 2021May 13, 2026Antitrust , Patent Law , Pharma

The following post comes from Austin Shaffer, a 2L at Scalia Law and a Research Assistant at CPIP.  By Austin Shaffer This past fall, the Department of Justice (DOJ) and […]

[Archived Post] Professor Daryl Lim Explores the Doctrine of Equivalents and Equitable Triggers

Posted on: December 17, 2020May 13, 2026Patent Law

The following post comes from Yumi Oda, an LLM Candidate at Scalia Law and a Research Assistant at CPIP. By Yumi Oda The term “claims” may not mean much to […]

[Archived Post] IP Scholars Question the Legality and Wisdom of Joint AG Proposal to Seize Remdesivir Patents

Posted on: December 16, 2020May 13, 2026Patents , Pharma

The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at CPIP. By Colin Kreutzer While the vaccines are starting to roll out in […]

Posts pagination

Page 1 Page 2 Page 3 Next page

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes